Anticoagulation of stented valves - What does the future hold (Segment 4)

The Cardiac Exchange
18/09/2023 9 min Episodio 36
Anticoagulation of stented valves - What does the future hold (Segment 4)

Listen "Anticoagulation of stented valves - What does the future hold (Segment 4)"

Descargar episodio Ver en sitio original

Episode Synopsis


Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

More episodes of the podcast The Cardiac Exchange

Durability and Lifetime Management of the Avalus™ Platform 24/09/2025
Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 3) 17/04/2025
Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 2) 17/04/2025
Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 1) 17/04/2025
Penditure Exclusion System: Left Atrial Appendage Management (Segment 2) 14/08/2024
Penditure Exclusion System: Left Atrial Appendage Management (Segment 1) 14/08/2024
Left Atrial Appendage Management (Segment 3) 26/02/2024
Left Atrial Appendage Management (Segment 2) 26/02/2024
Left Atrial Appendage Management (Segment 1) 26/02/2024
Anticoagulation of stented valves - Strategies based on patient age (Segment 3) 18/09/2023
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA